Insider Buying: Neuronetics, Inc. (NASDAQ:STIM) Director Pur

Neuronetics, Inc. (NASDAQ:STIM – Get Free Report) Director Robert Cascella bought 50,000 shares of Neuronetics stock in a transaction on Thursday, June 6th. The stock was acquired at an average price of $2.05 per share, with a total value of $102,500.00. Following the completion of the purchase, the director now directly owns 244,098 shares of […]

Related Keywords

United States , William Blair , Piper Sandler , Robert Cascella , Nasdaq , Worth Venture Partners , Dorsey Whitney Trust , Securities Exchange Commission , Sg Americas Securities , Fielder Capital Group , Neuronetics Inc , Investment Advisers , Get Free Report , Director Robert Cascella , Exchange Commission , Venture Partners , Whitney Trust , Capital Group , Neurostar Advanced Therapy System , Neuronetics Daily ,